Nov 1, 2018 Sanofi inks research deal with Denali in neurological, inflammatory diseases Sanofi inks research deal with Denali in neurological, inflammatory diseasesSanofi and Denali Therapeutics on Thursday announced a deal to jointly develop and potentially commercialize a set of small molecule compounds ... read morePublished on 2018-11-01